Sonablate HIFU registry for prostate cancer and BPH
Part of Cancer, Kidney & urinary clinical trials.
This study is a registry that collects information from men who have had Sonablate HIFU treatment for prostate cancer or enlarged prostate (BPH). It will help doctors learn more about how well this treatment works in real life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man diagnosed with prostate cancer or BPH (enlarged prostate).
- You have already had Sonablate HIFU treatment as part of your routine care.
- Your prostate is not too large for the treatment (under 100 cc for cancer, under 80 cc for BPH).
- Your cancer has not spread to other parts of the body.
- You have not had your prostate removed before.
- You do not have large calcium deposits in your prostate, and you can have a rectal ultrasound.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments for localized prostate cancer: high-intensity focused ultrasound (HIFU) using a device called Sonablate and robot-assisted surgery. It aims to see which works better and has fewer side effects.
This observational study looks at outcomes after people choose HIFU (high-intensity focused ultrasound) to treat only a targeted area of the prostate. It may help doctors better understand how well HIFU works and what follow-up imaging or testing shows over time.
This study collects data on men with early, low-risk prostate cancer who choose to have a targeted ultrasound treatment called HIFU (High-Intensity Focused Ultrasound). It looks at how well this treatment works and how men recover.
This trial tests a focused ultrasound treatment for benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate. It aims to see if HIFU can safely relieve symptoms like weak urine flow and frequent urination.
This study compares different ways to analyze ultrasound images in real time while treating localized prostate cancer with HIFU (a focused ultrasound treatment). It aims to improve how safely and accurately the treatment is monitored.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
Hear when a new Localized Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.